A view of Moderna headquarters in Cambridge, Mass., earlier this month. Moderna is touting preliminary data from a limited coronavirus vaccine trial.

A view of Moderna headquarters in Cambridge, Mass., earlier this month. Moderna is touting preliminary data from a limited coronavirus vaccine trial.